Log in
Enquire now
‌

US Patent 10017581 Methods and compositions for treatment of Pompe disease

Patent 10017581 was granted and assigned to Valerion Therapeutics on July, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Valerion Therapeutics
Valerion Therapeutics
Current Assignee
Valerion Therapeutics
Valerion Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10017581
Date of Patent
July 10, 2018
Patent Application Number
14769270
Date Filed
February 20, 2014
Patent Citations Received
‌
US Patent 12005121 Compositions and methods for delivery of nucleic acids to cells
0
‌
US Patent 11339406 Acid-alpha glucosidase variants and uses thereof
‌
US Patent 11850284 Compositions and methods for delivery of nucleic acids to cells
0
‌
US Patent 11872286 Compositions and methods for delivery of nucleic acids to cells
0
Patent Primary Examiner
‌
Karen Cochrane Carlson
Patent abstract

In certain embodiments, the present disclosure provides compositions and methods for treating Pompe disease.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10017581 Methods and compositions for treatment of Pompe disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.